基于纳米粒子治疗多药耐药 кандидоз感染的进展:综合性审查
Alireza Izadi1,2, Fatemeh Paknia3, Maryam Roostaee4
1Department of Medical Parasitology and Mycology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Nanotechnology
|May 15, 2024
概括
纳米粒子疗法在治疗多抗药性Candida auris感染方面表现有前途. 本综述强调了纳米材料的进步,以对抗这种全球性真菌威胁并改善患者的治疗结果.
科学领域:
- 菌类学 菌类学是指菌类学.
- 纳米技术纳米技术
- 传染性疾病 传染性疾病
背景情况:
- 黄是一种快速出现的多药耐药性真菌病原体,具有全球健康影响.
- 对于C. auris感染的传统检测和治疗方法越来越受到抗真菌耐药性的挑战.
- 多抗药性真菌感染的增加需要新的治疗策略.
研究的目的:
- 审查针对真菌感染的基于纳米粒子的治疗方法的最新进展.
- 强调纳米材料在对抗Candida auris感染方面的潜力.
- 探索纳米材料对抗多药耐药性真菌的作用机制和应用.
主要方法:
- 关于基于纳米粒子的抗真菌疗法的最新研究的文献综述.
- 分析各种纳米材料,包括银,碳,氧化,二氧化,聚合物和黄金.
- 研究纳米材料的作用机制和组合策略.
主要成果:
- 基于纳米颗粒的疗法在治疗皮肤角膜病的治疗中显示出显著的潜力.
- 各种纳米材料在对抗多药耐药性真菌病原体方面表现出有效性.
- 涉及纳米材料的组合疗法提供了增强的抗真菌活性.
结论:
- 基于纳米颗粒的疗法代表了对抗多药耐药性真菌感染,特别是Candida auris的有希望的前沿.
- 对纳米材料应用的进一步研究可以导致改善临床结果和降低死亡率.
- 这种方法开启了针对性和有效的抗真菌干预的新时代.
更多相关视频
06:39Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
927
09:06Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
Published on: March 29, 2024
719
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
